Dermata Therapeutics, Inc. · NASDAQ:DRMA
Proehl Gerald T received 170,068 Dermata Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 16, 2026 · Filed Aug 18, 2026
On Aug 16, 2026, Proehl Gerald T (Director, PRESIDENT, CHAIRMAN, CEO, 10% owner) received 170,068 Dermata Therapeutics, Inc. shares as an award, leaving 292,631 shares. Filed Aug 18, 2026 (Form 4).
- Awarded
- 170,068 shares
- Holding after
- 292,631 shares (held indirectly)
- Trading plan
- No
- Role
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 16, 2026 | Common Stock | Award | 170,068 | 292,631 | Indirect |
Source
Related
- Dermata Therapeutics, Inc.
- Proehl Gerald T
- Dermata Therapeutics, Inc. shareholders
- Form 4 · Van Hoose Kyri K. · Aug 18, 2026
- Form 4 · Scott Kathleen D. · Jun 16, 2026
- Schedule 13D · Van Hoose Kyri K. · Jun 1, 2026
- Schedule 13G/A · Mitchell P. Kopin · May 13, 2026
- Schedule 13D/A · Proehl Gerald T · Feb 23, 2026